Treatment with CML-AGE (10 μg/ml) resulted in a 25-fold and 45-fold increase in mRNA transcripts for the cytokines Tnfa and Il6 compared to vehicle, SFM (Fig. 5a,b, respectively). Here, IL6 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.